>
pdufa.bio

Vonoprazan

Updated ยทnext FDA decision on the calendar

Vonoprazan is a Phathom Pharmaceuticals, Inc. program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

PHAT catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Phathom Pharmaceuticals, Inc. (PHAT). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2026PHAT

Questions

When is Vonoprazan's next FDA decision or readout?

The next tracked catalyst for Vonoprazan is a Readout in Oct 2026.

What happened at Vonoprazan's most recent FDA decision?

No FDA decision for Vonoprazan is in our archive yet.

Who makes Vonoprazan?

Phathom Pharmaceuticals, Inc. (PHAT).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.